| 词条 | 5-HT receptor | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 释义 |
5-hydroxytryptamine receptors or 5-HT receptors, or serotonin receptors, are a group of G protein-coupled receptor and ligand-gated ion channels found in the central and peripheral nervous systems.[1][2][3] They mediate both excitatory and inhibitory neurotransmission. The serotonin receptors are activated by the neurotransmitter serotonin, which acts as their natural ligand. The serotonin receptors modulate the release of many neurotransmitters, including glutamate, GABA, dopamine, epinephrine / norepinephrine, and acetylcholine, as well as many hormones, including oxytocin, prolactin, vasopressin, cortisol, corticotropin, and substance P, among others. The serotonin receptors influence various biological and neurological processes such as aggression, anxiety, appetite, cognition, learning, memory, mood, nausea, sleep, and thermoregulation. The serotonin receptors are the target of a variety of pharmaceutical and recreational drugs, including many antidepressants, antipsychotics, anorectics, antiemetics, gastroprokinetic agents, antimigraine agents, hallucinogens, and entactogens.[4] Serotonin receptors are found in almost all animals and are even known to regulate longevity and behavioral aging in the primitive nematode, Caenorhabditis elegans.[5][6] Classification5-hydroxytryptamine receptors or 5-HT receptors, or serotonin receptors are found in the central and peripheral nervous systems.[1][2] They can be divided into 7 families of G protein-coupled receptors except for the 5-HT3 receptor, a ligand-gated ion channel, which activate an intracellular second messenger cascade to produce an excitatory or inhibitory response. In 2014, a novel 5-HT receptor was isolated from the small white butterfly, Pieris rapae, and named pr5-HT8. It does not occur in mammals and shares relatively low similarity to the known 5-HT receptor classes.[7] Families
SubtypesThe 7 general serotonin receptor classes include a total of 14 known serotonin receptors.[9] The specific types have been characterized as follows:[10][11][12]
Note that there is no 5-HT1C receptor since, after the receptor was cloned and further characterized, it was found to have more in common with the 5-HT2 family of receptors and was redesignated as the 5-HT2C receptor.[97] Very nonselective agonists of 5-HT receptor subtypes include ergotamine (an antimigraine), which activates 5-HT1A, 5-HT1D, 5-HT1B, D2 and norepinephrine receptors.[36] LSD (a psychedelic) is a 5-HT1A, 5-HT2A, 5-HT2C, 5-HT5A, 5-HT5, 5-HT6 agonist.[36] Expression patternsThe genes coding for serotonin receptors are expressed across the mammalian brain. Genes coding for different receptors types follow different developmental curves. Specifically, there is a developmental increase of HTR5A expression in several subregions of the human cortex, paralleled by a decreased expression of HTR1A from the embryonic period to the post-natal one. [98]5-HT{{sub|1}}-likeA number of receptors were classed as "5-HT{{sub|1}}-like" - by 1998 it was being argued that, since these receptors were "a heterogeneous population of 5-HT1B, 5-HT1D and 5-HT7" receptors the classification was redundant.[99] References1. ^1 {{cite journal |vauthors=Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP | title = International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin) | journal = Pharmacol. Rev. | volume = 46 | issue = 2 | pages = 157–203 | year = 1994 | pmid = 7938165 | doi = | issn = | url = http://pharmrev.aspetjournals.org/cgi/content/abstract/46/2/157}} 2. ^1 {{cite book |vauthors=Frazer A, Hensler JG |veditors=Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD | title = Basic Neurochemistry: MolecularCellular, and Medical Aspects | publisher = Lippincott-Raven | location = Philadelphia | year = 1999| pages = 263–292| isbn = 978-0-397-51820-3 | oclc = | doi = | chapter= Chapter 13: Serotonin Receptors | chapterurl = https://www.ncbi.nlm.nih.gov/books/bv.fcgi?call=bv.View..ShowSection&rid=bnchm.section.963 }} 3. ^{{Cite journal|last=Beliveau|first=Vincent|last2=Ganz|first2=Melanie|last3=Feng|first3=Ling|last4=Ozenne|first4=Brice|last5=Højgaard|first5=Liselotte|last6=Fisher|first6=Patrick M.|last7=Svarer|first7=Claus|last8=Greve|first8=Douglas N.|last9=Knudsen|first9=Gitte M.|date=2017-01-04|title=A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System|journal=Journal of Neuroscience|volume=37|issue=1|pages=120–128|doi=10.1523/jneurosci.2830-16.2016|pmid=28053035|pmc=5214625}} 4. ^{{cite journal |vauthors=Nichols DE, Nichols CD |title=Serotonin receptors |journal=Chem. Rev. |volume=108 |issue=5 |pages= 1614–41 |date=May 2008 |pmid=18476671 |doi=10.1021/cr078224o}} 5. ^{{cite journal | pmid = 17559503 | doi=10.1111/j.1474-9726.2007.00303.x | volume=6 | issue=4 | title=Serotonin receptors antagonistically modulate Caenorhabditis elegans longevity | date=August 2007 | pages=483–8 | journal=Aging Cell |vauthors=Murakami H, Murakami S }} 6. ^{{cite journal | pmid = 17336425 | doi=10.1016/j.neurobiolaging.2007.01.013 | volume=29 | issue=7 | title=Manipulation of serotonin signal suppresses early phase of behavioral aging in Cnorhabditis elegans | date=July 2008 | pages=1093–100 | journal=Neurobiology of Aging |vauthors=Murakami H, Bessinger K, Hellmann J, Murakami S }} 7. ^{{cite journal |vauthors=Qi YX, Xia RY, Wu YS, Stanley D, Huang J, Ye GY |title=Larvae of the small white butterfly, Pieris rapae, express a novel serotonin receptor |journal=J. Neurochem. |volume= 131|issue= 6|pages= 767–77|year=2014 |pmid=25187179 |doi=10.1111/jnc.12940 |url=}} 8. ^{{cite journal |vauthors=Francken BJ, Jurzak M, Vanhauwe JF, Luyten WH, Leysen JE | title = The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells. | journal = Eur J Pharmacol | volume = 361 | issue = 2–3 | pages = 299–309 | year = 1998 | pmid = 9865521 | doi = 10.1016/S0014-2999(98)00744-4 }} 9. ^{{cite book |vauthors=Malenka RC, Nestler EJ, Hyman SE |veditors=Sydor A, Brown RY | title = Molecular Neuropharmacology: A Foundation for Clinical Neuroscience | year = 2009 | publisher = McGraw-Hill Medical | location = New York | isbn = 9780071481274 | page = 4 | edition = 2nd |quote = Similarly, little is known about which of serotonin’s 14 known receptors must be activated to achieve an antidepressant response. }} 10. ^{{cite web | url = http://www.acnp.org/g4/GN401000039/Ch039.html | title = Serotonin Receptor Subtypes and Ligands | accessdate = 2008-04-11 |vauthors=Glennon RA, Dukat M, Westkaemper RB | date = 2000-01-01 | website = | publisher = American College of Neurophyscopharmacology | pages = | language = | quote = | archiveurl= https://web.archive.org/web/20080421160353/http://www.acnp.org/g4/GN401000039/Ch039.html| archivedate= 21 April 2008 | deadurl= no}} 11. ^{{cite web | url = http://www.iuphar-db.org/GPCR/ChapterMenuForward?chapterID=1288 | title = 5-Hydroxytryptamine Receptors | accessdate = 2008-04-11 | date = | format = | work = IUPHAR Receptor Database | publisher = International Union of Basic and Clinical Pharmacology | pages = | language = | quote = }} 12. ^{{cite journal |author=Wesolowska A |title=In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors |journal=Polish Journal of Pharmacology |volume=54 |issue=4 |pages=327–41 |year=2002 |pmid=12523486 |url=http://www.if-pan.krakow.pl/pjp/pdf/2002/4_327.pdf}} 13. ^{{cite journal |vauthors=Tomkins DM, Higgins GA, Sellers EM | title = Low doses of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH DPAT) increase ethanol intake | journal = Psychopharmacology | volume = 115 | issue = 1–2 | pages = 173–9 | year = 1994 | pmid = 7862892 | doi = 10.1007/BF02244769 }} 14. ^{{cite journal |vauthors=Müller CP, Carey RJ, Huston JP, De Souza Silva MA | title = Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors | journal = Prog. Neurobiol. | volume = 81 | issue = 3 | pages = 133–78 | year = 2007 | pmid = 17316955 | doi = 10.1016/j.pneurobio.2007.01.001 }} 15. ^{{cite journal |vauthors=Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Müller CP, Huston JP | title = Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects | journal = Brain Res. | volume = 1034 | issue = 1–2 | pages = 162–71 | year = 2005 | pmid = 15713268 | doi = 10.1016/j.brainres.2004.12.012 }} 16. ^1 {{cite journal |vauthors=de Boer SF, Koolhaas JM | title = 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis | journal = Eur J Pharmacol | volume = 526 | issue = 1–3 | pages = 125–39 | year = 2005 | pmid = 16310183 | doi = 10.1016/j.ejphar.2005.09.065 }} 17. ^{{cite journal |vauthors=Parks CL, Robinson PS, Sibille E, Shenk T, Toth M | title = Increased anxiety of mice lacking the serotonin1A receptor | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 95| issue = 18 | pages = 10734–9 | year = 1998 | pmid = 9724773 | pmc = 27964 | doi=10.1073/pnas.95.18.10734}} 18. ^{{cite journal |vauthors=Ebenezer IS, Arkle MJ, Tite RM | title = 8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors | journal = Methods Find Exp Clin Pharmacol | volume = 29 | issue = 4 | pages = 269–72 | year = 1998 | pmid = 17609739 | doi = 10.1358/mf.2007.29.4.1075362 }} 19. ^1 {{cite journal |vauthors=Wouters W, Tulp MT, Bevan P | title = Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors | journal = Eur J Pharmacol | volume = 149 | issue = 3 | pages = 213–23 | year = 1998 | pmid = 2842163 | doi = 10.1016/0014-2999(88)90651-6 }} 20. ^1 {{cite journal |vauthors=Horiuchi J, McDowall LM, Dampney RA | title = Role of 5-HT(1A) receptors in the lower brainstem on the cardiovascular response to dorsomedial hypothalamus activation | journal = Auton Neurosci. | volume = 142 | issue = 1–2 | pages = 71–6 | year = 2008 | pmid = 18667366 | doi = 10.1016/j.autneu.2008.06.004 }} 21. ^{{cite journal |vauthors=Nalivaiko E, Ootsuka Y, Blessing WW | title = Activation of 5-HT1A receptors in the medullary raphe reduces cardiovascular changes elicited by acute psychological and inflammatory stresses in rabbits | journal = Am J Physiol Regul Integr Comp Physiol | volume = 289 | issue = 2 | pages = R596–R604 | year = 2005 | pmid = 15802554 | doi = 10.1152/ajpregu.00845.2004 }} 22. ^1 {{cite journal | author = Lucot JB. | title = Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin | journal = Eur J Pharmacol | volume = 253 | issue = 1–2 | pages = 53–60 | year = 1994 | pmid = 8013549 | doi = 10.1016/0014-2999(94)90756-0 }} 23. ^{{cite journal |vauthors=Winstanley CA, Theobald DE, Dalley JW, Robbins TW | title = Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders | journal = Neuropsychopharmacology | volume = 30 | issue = 4 | pages = 669–682 | year = 2005 | pmid = 15688093 | doi = 10.1038/sj.npp.1300610 }} 24. ^{{cite journal |vauthors=Ogren SO, Eriksson TM, Elvander-Tottie E, D'Addario C, Ekström JC, Svenningsson P, Meister B, Kehr J, Stiedl O | title = The role of 5-HT(1A) receptors in learning and memory | journal = Behav. Brain Res. | volume = 195 | issue = 1 | pages = 54–77 | year = 2008 | pmid = 18394726 | doi = 10.1016/j.bbr.2008.02.023 }} 25. ^{{cite journal |vauthors=Yasuno F, Suhara T, Nakayama T, Ichimiya T, Okubo Y, Takano A, Ando T, Inoue M, Maeda J, Suzuki K | title = Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory | journal = Am J Psychiatry | volume = 160 | issue = 2 | pages = 334–40 | year = 2003 | pmid = 12562581 | doi = 10.1176/appi.ajp.160.2.334 }} 26. ^{{cite journal |vauthors=Kennett GA, Dourish CT, Curzon G | title = Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression | journal = Eur J Pharmacol | volume = 134 | issue = 3 | pages = 265–74 | year = 1987 | pmid = 2883013 | doi = 10.1016/0014-2999(87)90357-8 }} 27. ^{{cite journal |vauthors=Bardin L, Tarayre JP, Malfetes N, Koek W, Colpaert FC | title = Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain | journal = Pharmacology | volume = 67 | issue = 4 | pages = 182–194 | year = 2003 | pmid = 12595749 | doi = 10.1159/000068404 }} 28. ^1 {{cite journal |vauthors=Millan MJ, Perrin-Monneyron S | title = Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors | journal = Eur J Pharmacol | volume = 321 | issue = 3 | pages = 11–3 | year = 1997 | pmid = 9085055 | doi=10.1016/S0014-2999(97)00050-2}} 29. ^{{cite journal |vauthors=Prow MR, Martin KF, Heal DJ | title = 8-OH-DPAT-induced mydriasis in mice: a pharmacological characterisation | journal = Eur J Pharmacol | volume = 317 | issue = 1 | pages = 21–8 | year = 1996 | pmid = 8982715 | doi = 10.1016/S0014-2999(96)00693-0 }} 30. ^1 {{cite journal |vauthors=Meyer LC, Fuller A, Mitchell D | title = Zacopride and 8-OH-DPAT reverse opioid-induced respiratory depression and hypoxia but not catatonic immobilization in goats | journal = American Journal of Physiology. Regulatory, Integrative and Comparative Physiology | volume = 290 | issue = 2 | pages = R405–13 |date=February 2006 | pmid = 16166206 | doi = 10.1152/ajpregu.00440.2005 | url = | issn = }} 31. ^1 {{cite journal |vauthors=Popova NK, Amstislavskaya TG | title = Involvement of the 5-HT(1A) and 5-HT(1B) serotonergic receptor subtypes in sexual arousal in male mice | journal = Psychoneuroendocrinology | volume = 27 | issue = 5 | pages = 609–18 | year = 2002 | pmid = 11965359 | doi = 10.1016/S0306-4530(01)00097-X }} 32. ^{{cite journal |vauthors=Monti JM, Jantos H | title = Dose-dependent effects of the 5-HT1A receptor agonist 8-OH-DPAT on sleep and wakefulness in the rat | journal = J Sleep Res | volume = 1 | issue = 3 | pages = 169–175 | year = 1992 | pmid = 10607047 | doi = 10.1111/j.1365-2869.1992.tb00033.x }} 33. ^{{cite journal |vauthors=Thompson MR, Callaghan PD, Hunt GE, Cornish JL, McGregor IS | title = A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy") | journal = Neuroscience | volume = 146 | issue = 2 | pages = 509–14 | year = 2007 | pmid = 17383105 | doi = 10.1016/j.neuroscience.2007.02.032 }} 34. ^{{cite journal |vauthors=Gudelsky GA, Koenig JI, Meltzer HY | title = Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors | journal = Neuropharmacology | volume = 25 | issue = 12 | pages = 1307–13 | year = 1986 | pmid = 2951611 | doi = 10.1016/0028-3908(86)90101-2 }} 35. ^{{cite journal |vauthors=Ootsuka Y, Blessing WW | title = Activation of 5-HT1A receptors in rostral medullary raphé inhibits cutaneous vasoconstriction elicited by cold exposure in rabbits | journal = Brain Res. | volume = 1073–1074 | pages = 252–61 | year = 2006 | pmid = 16455061 | doi = 10.1016/j.brainres.2005.12.031 }} 36. ^1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Pharmacology Corner > Serotonin (5-HT): receptors, agonists and antagonists By Flavio Guzmán, M.D. on 9/08/09 37. ^1 2 3 4 "BRINTELLIX™ (vortioxetine) tablets for oral use. Full Prescribing Information, Section 12.2 (Pharmacodynamics)." Takeda Pharmaceuticals America Inc. and Lundbeck, 2013. Revised September 2013. 38. ^{{cite journal|last=Saxena|first=PR|author2=Lawang, A|title=A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors.|journal=Archives Internationales de Pharmacodynamie et de Thérapie|date=Oct 1985|volume=277|issue=2|pages=235–52|pmid=2933009}} 39. ^{{cite journal |vauthors=Cao BJ, Rodgers RJ |title=Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice |journal=Psychopharmacology |volume=139 |issue=3 |pages=185–94 |date=October 1998 |pmid=9784072 |doi= 10.1007/s002130050703|url=}} 40. ^{{cite journal |vauthors=Harrison AA, Parsons LH, Koob GF, Markou A | title = RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist | journal = Psychopharmacology | volume = 141 | issue = 3 | pages = 242–50 | year = 1999 | pmid = 10027505 | doi = 10.1007/s002130050831 }} 41. ^{{cite journal |vauthors=Chojnacka-Wójcik E, Klodzinska A, Tatarczynska E | title = The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action | journal = J Pharm Pharmacol | volume = 57 | issue = 2 | pages = 253–7 | year = 2005 | pmid = 15720791 | doi = 10.1211/0022357055399 }} 42. ^{{cite journal |vauthors=Lin D, Parsons LH | title = Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze | journal = Pharmacol Biochem Behav | volume = 71 | issue = 4 | pages = 581–7 | year = 2002 | pmid = 11888549 | doi = 10.1016/S0091-3057(01)00712-2 }} 43. ^1 {{cite journal |vauthors=Tatarczynska E, Klodzinska A, Stachowicz K, Chojnacka-Wójcik E | title = Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression | journal = Behav Pharmacol | volume = 15 | issue = 8 | pages = 523–34 | year = 2004 | pmid = 15577451 | doi = 10.1097/00008877-200412000-00001 }} 44. ^1 {{cite journal |vauthors=Eriksson TM, Madjid N, Elvander-Tottie E, Stiedl O, Svenningsson P, Ogren SO | title = Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission | journal = Neuropharmacology | volume = 54 | issue = 7 | pages = 1041–50 | year = 2008 | pmid = 18394658 | doi = 10.1016/j.neuropharm.2008.02.007 }} 45. ^1 {{cite journal |vauthors=McCreary AC, Bankson MG, Cunningham KA | title = Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors | journal = J Pharmacol Exp Ther | volume = 290 | issue = 3 | pages = 965–73 | year = 1999 | pmid = 10454466 }} 46. ^{{cite journal |vauthors=Amital D, Fostick L, Sasson Y, Kindler S, Amital H, Zohar J | title = Anxiogenic effects of Sumatriptan in panic disorder: a double-blind, placebo-controlled study | journal = Eur Neuropsychopharmacol | volume = 15 | issue = 3 | pages = 279–82 | year = 2005 | pmid = 15820416 | doi = 10.1016/j.euroneuro.2004.12.002 }} 47. ^{{cite journal |vauthors=Feuerstein TJ, Hüring H, van Velthoven V, Lücking CH, Landwehrmeyer GB | title = 5-HT1D-like receptors inhibit the release of endogenously formed [3H]GABA in human, but not in rabbit, neocortex | journal = Neurosci. Lett. | volume =209 | issue = 3 | pages = 210–4 | year = 1996 | pmid = 8736648 | doi = 10.1016/0304-3940(96)12637-9 }} 48. ^1 {{cite journal | pmid = 17017968 | volume=6 | issue=18 | title=Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence | year=2006 | journal=Curr Top Med Chem | pages=1971–85 | vauthors=Bubar MJ, Cunningham KA | doi=10.2174/156802606778522131}} 49. ^{{cite journal |vauthors=Schreiber R, Melon C, De Vry J | title = The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test | journal = Psychopharmacology | volume = 135 | issue = 4 | pages = 383–91 | year = 1998 | pmid = 9539263 | doi = 10.1007/s002130050526 }} 50. ^1 {{cite journal |vauthors=Popova NK, Amstislavskaya TG | title = 5-HT2A and 5-HT2C serotonin receptors differentially modulate mouse sexual arousal and the hypothalamo-pituitary-testicular response to the presence of a female | journal = Neuroendocrinology | volume = 76 | issue = 1 | pages = 28–34 | year = 2002 | pmid = 12097814 | doi = 10.1159/000063681 }} 51. ^1 {{cite journal |vauthors=Popa D, Léna C, Fabre V, Prenat C, Gingrich J, Escourrou P, Hamon M, Adrien J | title = Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors | journal = J. Neurosci. | volume = 25 | issue = 49 | pages = 11231–8 | year = 2005 | pmid = 16339018 | doi = 10.1523/JNEUROSCI.1724-05.2005 }} 52. ^1 {{cite journal |vauthors=Mazzola-Pomietto P, Aulakh CS, Tolliver T, Murphy DL | title = Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists| journal = Psychopharmacology | volume = 130 | issue = 2 | pages = 144–51 | year = 1997 | pmid = 9106912 | doi = 10.1007/s002130050222 }} 53. ^{{cite journal |vauthors=Blessing WW, Seaman B | title = 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats | journal = Neuroscience | volume = 117 | issue = 4 | pages = 939–948 | year = 2003 | pmid = 12654345 | doi = 10.1016/S0306-4522(02)00810-2 }} 54. ^1 2 {{cite journal |author1= McCall, R. B. |author2= Franklin, S. R. |author3= Hyslop, D. K. |author4= Knauer, C. S. |author5= Chio, C. L. |author6= Haber, C. L. |author7= Fitzgerald, L. W. |title= PNU-22394, a 5-HT2C receptor agonist, reduced feeding in rodents and produces weight loss in humans |date= 2001 |conference= Society for Neuroscience |others= Presentation Number 309.2 | volume = 27 | issue = 309.2 |publisher= Society for Neuroscience Abstracts |url= http://www.sfn.org/Annual-Meeting/Past-and-Future-Annual-Meetings/Abstract-Archive/Abstract-Archive-Detail?AbsYear=2001&AbsID=4715 |location= Convention Center Exhibit Hall, Poster Board TT-45, San Diego, CA |format= Online |accessdate= 18 July 2014}} 55. ^1 2 {{cite journal |vauthors=Garfield AS, Heisler LK | title = Pharmacological targeting of the serotonergic system for the treatment of obesity | journal = The Journal of Physiology | year = 2009 | volume = 587 | issue = 1 | pages = 49–60 | doi = 10.1113/jphysiol.2008.164152 | pmc = 2670022 | pmid=19029184}} 56. ^1 2 {{cite journal | author1 = Jensen, Anders A. | author2 = Plath, Niels | author3 = Pedersen, Martin Holst Friborg | author4 = Isberg, Vignir | author5 = Krall, Jacob | author6 = Wellendorph, Petrine | author7 = Stensbøl, Tine B. | author8 = Gloriam, David E. | author9 = Krogsgaard-Larsen, Povl | author10 = Frølund, Bente | display-authors = 4 | title = Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties | journal = Journal of Medicinal Chemistry | year = 2013 | volume = 56 | issue = 3 | pages = 1211–1227 | doi = 10.1021/jm301656h | pmid = 23301527 | issn = 0022-2623| citeseerx = 10.1.1.691.154 }} 57. ^{{cite journal |vauthors=Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP | title = Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety | journal = Br J Pharmacol| volume = 117 | issue = 7 | pages = 1443–8 | year = 1996 | pmid = 8730737 | pmc = 1909458 | doi=10.1111/j.1476-5381.1996.tb15304.x}} 58. ^{{cite journal |vauthors=Duxon MS, Kennett GA, Lightowler S, Blackburn TP, Fone KC | title = Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat | journal = Neuropharmacology | volume = 36 | issue = 4–5 | pages = 601–8 | year = 1997 | pmid = 9225285 | doi = 10.1016/S0028-3908(97)00042-7 }} 59. ^{{cite journal |vauthors=Kennett GA, Trail B, Bright F | title = Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated | journal = Neuropharmacology | volume = 37 | issue = 12 | pages = 1603–10 | year = 1998 | pmid = 9886683 | doi = 10.1016/S0028-3908(98)00115-4 }} 60. ^{{cite journal |vauthors=Kennett GA, Ainsworth K, Trail B, Blackburn TP | title = BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats | journal = Neuropharmacology | volume = 36 | issue = 2 | pages = 233–9 | year = 1997 | pmid = 9144661 | doi = 10.1016/S0028-3908(96)00171-2 }} 61. ^{{cite journal |vauthors=Borman RA, Tilford NS, Harmer DW, Day N, Ellis ES, Sheldrick RL, Carey J, Coleman RA, Baxter GS | title = 5-HT(2B) receptors play a key role in mediating the excitatory effects of 5-HT in human colon in vitro | journal = Br J Pharmacol| volume = 135 | issue = 5 | pages = 1144–1151 | year = 2002 | pmid = 11877320 | doi = 10.1038/sj.bjp.0704571 | pmc = 1573235 }} 62. ^{{cite journal |vauthors=Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, Forbes IT, Brown AM, Middlemiss DN, Blackburn TP | title = SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist | journal = Neuropharmacology | volume = 36 | issue = 4–5 | pages = 609–20 | year = 1997 | pmid = 9225286 | doi = 10.1016/S0028-3908(97)00038-5 }} 63. ^1 {{cite journal |vauthors=Millan MJ, Brocco M, Gobert A, Dekeyne A | title = Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade | journal = Psychopharmacology | volume = 177 | issue = 4 | pages = 448–58 | year = 2005 | pmid = 15289999 | doi = 10.1007/s00213-004-1962-z }} 64. ^1 {{cite journal |vauthors=Millan MJ, Brocco M, Gobert A, Dekeyne A | title = S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models | journal = Psychopharmacology | volume = 199 | issue = 4 | pages = 549–68 | year = 2008 | pmid = 18523738 | doi = 10.1007/s00213-008-1177-9 }} 65. ^{{cite journal |vauthors=Fujitsuka N, Asakawa A, Hayashi M, Sameshima M, Amitani H, Kojima S, Fujimiya M, Inui A | title = Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin | journal = Biol Psychiatry | volume = 65 | issue = 9 | pages = 748–759 | year = 2009 | pmid = 19058784 | doi = 10.1016/j.biopsych.2008.10.031 }} 66. ^{{cite journal |vauthors=Millan MJ, Peglion JL, Lavielle G, Perrin-Monneyron S | title = 5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists | journal = Eur J Pharmacol | volume = 325 | issue = 1 | pages = 9–12 | year = 1997 | pmid = 9151932 | doi = 10.1016/S0014-2999(97)89962-1 }} 67. ^{{cite journal |vauthors=Stancampiano R, Melis MR, Argiolas A | title = Penile erection and yawning induced by 5-HT1C receptor agonists in male rats: relationship with dopaminergic and oxytocinergic transmission | journal = Eur J Pharmacol | volume = 261 | issue = 1–2 | pages = 149–55 | year = 1994 | pmid = 8001637 | doi = 10.1016/0014-2999(94)90313-1 }} 68. ^{{cite journal |vauthors=Frank MG, Stryker MP, Tecott LH | title = Sleep and sleep homeostasis in mice lacking the 5-HT2c receptor | journal = Neuropsychopharmacology | volume = 27 | issue = 5 | pages = 869–73 | year = 2002 | pmid = 12431861 | doi = 10.1016/S0893-133X(02)00353-6 | pmc = 2452994 }} 69. ^{{cite book |author=Rang, H. P. |title=Pharmacology |publisher=Churchill Livingstone |location=Edinburgh |year=2003 |pages= |isbn=978-0-443-07145-4 |oclc= |doi=}} Page 187 70. ^{{cite web|title=Serotonin excites neurons in the human submucous plexus via 5-HT3 receptors.|url=https://www.ncbi.nlm.nih.gov/pubmed?cmd=historysearch&querykey=1|vauthors=Michel K, Zeller F, Langer R, Nekarda H, Kruger D, Dover TJ, Brady CA, Barnes NM, Schemann M |publisher=National Center for Biotechnology Information|accessdate=10 October 2014|date=May 2005}} 71. ^1 {{cite journal |vauthors=Pitsikas N, Brambilla A, Borsini F | title = Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task | journal = Pharmacol Biochem Behav | volume = 47 | issue = 1 | pages = 95–99 | year = 1994 | pmid = 8115433 | doi = 10.1016/0091-3057(94)90116-3 }} 72. ^1 {{cite journal |vauthors=Smriga M, Torii K | title = L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 100 | issue = 26 | pages = 15370–5 | year = 2003 | pmid = 14676321 | doi = 10.1073/pnas.2436556100 | pmc = 307574 }} 73. ^{{cite journal |vauthors=Kennett GA, Bright F, Trail B, Blackburn TP, Sanger GJ | title = Anxiolytic-like actions of the selective 5-HT4 receptor antagonists SB 204070A and SB 207266A in rats | journal = Neuropharmacology | volume = 36 | issue = 4–5 | pages = 707–12 | year = 1997 | pmid = 9225297 | doi = 10.1016/S0028-3908(97)00037-3 }} 74. ^{{cite journal |vauthors=Jean A, Conductier G, Manrique C, Bouras C, Berta P, Hen R, Charnay Y, Bockaert J, Compan V | title = Anorexia induced by activation of serotonin 5-HT4 receptors is mediated by increases in CART in the nucleus accumbens | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 104 | issue = 41 | pages = 16335–40 | year = 2007 | pmid = 17913892 | doi = 10.1073/pnas.0701471104 | pmc = 2042207 }} 75. ^{{cite journal | title = Feeding disorders in 5-HT4 receptor knockout mice | journal = J Soc Biol | volume = 198 | issue = 1 | pages = 37–49 | year = 2004 | pmid = 15146954 |author1=Compan V | last2 = Charnay | first2 = Y | last3 = Dusticier | first3 = N | last4 = Daszuta | first4 = A | last5 = Hen | first5 = R | last6 = Bockaert | first6 = J | doi = 10.1051/jbio/2004198010037 }} 76. ^1 {{cite journal |vauthors=Meneses A, Hong E |title=Effects of 5-HT4 receptor agonists and antagonists in learning |journal=Pharmacol Biochem Behav |volume=56 |issue=3 |pages=347–51 |year=1997 |pmid=9077568 |doi=10.1016/S0091-3057(96)00224-9}} 77. ^1 {{cite journal |vauthors=Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM | title = The effects of novel, selective 5-hydroxytryptamine (5-HT)4 receptor ligands in rat spatial navigation | journal = Neuropharmacology | volume = 36 | issue = 4–5 | pages = 689–96 | year = 1997 | pmid = 9225295 | doi = 10.1016/S0028-3908(97)00055-5 }} 78. ^{{cite journal |vauthors=Fontana DJ, Daniels SE, Wong EH, Clark RD, Eglen RM | title = Role of 5-HT4 receptors in the mouse passive avoidance test | journal = J Pharmacol Exp Ther | volume = 286 | issue = 3 | pages = 1115–21 | year = 1998 | pmid = 9732367 }} 79. ^{{Cite journal | last1 = Lucas | first1 = G. | last2 = Rymar | first2 = V. V. | last3 = Du | first3 = J. | last4 = Mnie-Filali | first4 = O. | last5 = Bisgaard | first5 = C. | last6 = Manta | first6 = S. | last7 = Lambas-Senas | first7 = L. | last8 = Wiborg | first8 = O. | last9 = Haddjeri | first9 = N. | last10 = Piñeyro | first10 = G. | last11 = Sadikot | first11 = A. F. | last12 = Debonnel | first12 = G. | doi = 10.1016/j.neuron.2007.07.041 | title = Serotonin4 (5-HT4) Receptor Agonists Are Putative Antidepressants with a Rapid Onset of Action | journal = Neuron | volume = 55 | issue = 5 | pages = 712–725 | year = 2007 | pmid = 17785179| pmc = }} 80. ^{{Cite journal | last1 = Duman | first1 = R. S. | title = A Silver Bullet for the Treatment of Depression? | doi = 10.1016/j.neuron.2007.08.011 | journal = Neuron | volume = 55 | issue = 5 | pages = 679–681 | year = 2007 | pmid = 17785173| pmc = }} 81. ^{{cite journal|last1=Manzke|first1=T.|title=5-HT4(a) Receptors Avert Opioid-Induced Breathing Depression Without Loss of Analgesia|journal=Science|volume=301|issue=5630|year=2003|pages=226–229|issn=0036-8075|doi=10.1126/science.1084674|pmid=12855812}} 82. ^{{cite journal | author = Nelson DL | title = 5-HT5 receptors | journal = Curr Drug Targets CNS Neurol Disord | volume =3 | issue = 1 | pages = 53–8 | year = 2004 | pmid = 14965244 | doi = 10.2174/1568007043482606 }} 83. ^1 {{cite journal |vauthors=Dietz BM, Mahady GB, Pauli GF, Farnsworth NR | title = Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro | journal = Brain Res Mol Brain Res | volume = 138 | issue = 2 | pages = 191–7 | year = 2005 | pmid = 15921820 | pmc = 5805132 | doi = 10.1016/j.molbrainres.2005.04.009 }} 84. ^{{cite journal | author = Wesolowska A | title = The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors | journal = European Journal of Pharmacology | volume = 580 | issue = 3 | pages = 355–60 |date=February 2008 | pmid = 18096153 | doi = 10.1016/j.ejphar.2007.11.022 | url = | issn = }} 85. ^1 {{cite journal |vauthors=Wesolowska A, Nikiforuk A | title = Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression | journal = Neuropharmacology | volume = 52 | issue = 5 | pages = 1274–83 |date=April 2007 | pmid = 17320917 | doi = 10.1016/j.neuropharm.2007.01.007 | url = | issn = }} 86. ^{{cite journal |vauthors=Hirst WD, Stean TO, Rogers DC, Sunter D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Bartlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N | title = SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models | journal = European Journal of Pharmacology | volume = 553 | issue = 1–3 | pages = 109–19 |date=December 2006 | pmid = 17069795 | doi = 10.1016/j.ejphar.2006.09.049 | url = | issn = }} 87. ^1 {{cite journal |vauthors=Perez-García G, Meneses A | title = Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task | journal = Pharmacology Biochemistry and Behavior | volume = 81 | issue = 3 | pages = 673–82 |date=July 2005 | pmid = 15964617 | doi = 10.1016/j.pbb.2005.05.005 | url = | issn = }} 88. ^{{cite journal |vauthors=Wesolowska A, Nikiforuk A | title = The selective 5-HT(6) receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats | journal = European Journal of Pharmacology | volume = 582 | issue = 1–3 | pages = 88–93 |date=March 2008 | pmid = 18234190 | doi = 10.1016/j.ejphar.2007.12.013 | url = | issn = }} 89. ^{{cite web|url=http://www.abpi.org.uk/publications/publication_details/targetSchizophrenia-2003/section5.asp |title=Target Schizophrenia - Possible future developments |accessdate=2008-04-11 |date= |format= |website= |publisher=The Association of the British Pharmaceutical Industry |pages= |language= |archiveurl=https://web.archive.org/web/20080612135635/http://www.abpi.org.uk/publications/publication_details/targetSchizophrenia-2003/section5.asp |archivedate=2008-06-12 |quote= |deadurl=yes |df= }} 90. ^1 2 {{cite journal |vauthors=Hedlund PB, Huitron-Resendiz S, Henriksen SJ, Sutcliffe JG | title = 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern | journal = Biological Psychiatry | volume = 58 | issue = 10 | pages = 831–7 |date=November 2005 | pmid = 16018977 | doi = 10.1016/j.biopsych.2005.05.012 | url = | issn = }} 91. ^1 {{cite journal |vauthors=Wesolowska A, Nikiforuk A, Stachowicz K, Tatarczynska E | title = Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression | journal = Neuropharmacology | volume = 51 | issue = 3 | pages = 578–86 |date=September 2006 | pmid = 16828124 | doi = 10.1016/j.neuropharm.2006.04.017 | url = | issn = }} 92. ^{{cite journal |vauthors=Gasbarri A, Cifariello A, Pompili A, Meneses A | title = Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat | journal = Behavioural Brain Research | volume = 195 | issue = 1 | pages = 164–70 |date=December 2008 | pmid = 18308404 | doi = 10.1016/j.bbr.2007.12.020 | url = | issn = }} 93. ^{{cite journal |vauthors=Liy-Salmeron G, Meneses A | title = Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model | journal = Hippocampus | volume = 18 | issue = 9 | pages = 965–74 | year = 2008 | pmid = 18570192 | doi = 10.1002/hipo.20459 | url = | issn = }} 94. ^1 {{cite journal |vauthors=Bonaventure P, Kelly L, Aluisio L, Shelton J, Lord B, Galici R, Miller K, Atack J, Lovenberg TW, Dugovic C | title = Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents | journal = J Pharmacol Exp Ther | volume = 321 | issue = 2 | pages = 690–8 | year = 2007 | pmid = 17314195 | doi = 10.1124/jpet.107.119404 }} 95. ^{{cite journal |vauthors=Thomas DR, Melotto S, Massagrande M, Gribble AD, Jeffrey P, Stevens AJ, Deeks NJ, Eddershaw PJ, Fenwick SH, Riley G, Stean T, Scott CM, Hill MJ, Middlemiss DN, Hagan JJ, Price GW, Forbes IT | title = SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats | journal = Br J Pharmacol| volume = 139 | issue = 4 | pages = 705–14 | year = 2003 | pmid = 12812993 | doi = 10.1038/sj.bjp.0705290 | pmc = 1573887 }} 96. ^Davies MA, Sheffler DJ, Roth BL. Aripiprazole: A Novel Atypical Antipsychotic Drug With a Uniquely Robust Pharmacology. CNS Drug Reviews [Internet]. 2004 [cited 2013 Aug 4];10(4):317–36. Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1527-3458.2004.tb00030.x/pdf 97. ^{{cite web |url= https://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&dopt=full_report&list_uids=3358 |title= HTR2C 5-hydroxytryptamine receptor 2C [ Homo sapiens (human) ] |date= 19 Mar 2017 |website= NCBI |access-date= 26 Mar 2017}} 98. ^{{cite journal |vauthors=Bar-Shira O, Maor R, Chechik G| title = Gene Expression Switching of Receptor Subunits in Human Brain Development | journal = PLoS Computational Biology| date=2015 | pmid = 26636753 | doi = 10.1371/journal.pcbi.1004559 | volume=11 | issue = 12 | pmc=4670163 | page=e1004559}} 99. ^{{Cite journal | doi=10.1016/S0165-6147(98)01228-0|title = 5-HT 1 -like receptors: A time to bid goodbye| journal=Trends in Pharmacological Sciences| volume=19| issue=8| pages=311–316|year = 1998|last1 = Saxena|first1 = P.R.| last2=De Vries| first2=P.| last3=Villalón| first3=C.M.}} External links
1 : Serotonin receptors |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 随便看 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。